Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
New non-opioid painkiller Journavx approved by FDA
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
11h
on MSN
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...
13h
on MSN
Brand-new painkiller approved by US health agency
Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 million ...
AFP
20h
Vertex Announces FDA Approval of JOURNAVXâ„¢ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Small plane crashes in Philly
Black boxes recovered
Receives $250K settlement
Boy, 5, dies in explosion
Cause of death revealed
Todd exits NBC News
Granted legal personhood
Apologizes for old tweets
IL won’t hire Jan. 6 rioters
Activists call for boycott
Gold hits all-time high
To again run for Senate?
Tour boat captain sentenced
Opens probe into NPR, PBS
Cancerous tumor removed
Seeking a new trial
FDA approves painkiller
Drone pilot to plead guilty
Ends abortion travel policy
Walgreens suspends dividend
Ground stop amid IT outage
Partners w/ US national labs
WBD hit with copyright suit
Confirmed interior secretary
New York doctor indicted
Olympic gold medalist dies
'As Tears Go By' singer dies
Top leaders asked to resign
US inflation ticked higher
To raise hourly pay
Recuses self from Act 10 suit
Inmate's transfer blocked
Michigan priest loses license
Feedback